Blood glucose monitoring systems

Main article: Diabetes mellitus

• Human blood

2025

Miniature implant for continuous blood glucose monitoring entered the market

In mid-August 2025, Lifecare, based in Bergen (Norway), announced the release of a miniature implant for continuous blood glucose monitoring. The product is designed to improve the quality of life of patients with diabetes. Read more here.

Electrocatalyst based on iron and nickel complexes with cyanides will allow biosensors to continuously measure glucose for several days

Scientists have created an ultra-stable electrocatalyst that allows biosensors that measure glucose levels to run continuously for several days without losing sensitivity. This is fundamentally important for monitoring the condition of patients with diabetes mellitus with minimally invasive and non-invasive wearable devices, excluding the need for their calibration related to blood sampling. This was announced by the Russian Scientific Foundation (RSF) on July 11, 2025. Read more here.

2024

Sales of global glucose monitoring systems for the year reached $17.2 billion

In 2024, the global market for blood glucose monitoring systems amounted to $17.2 billion. More than 40% of sales in monetary terms were provided by the North American region. This is stated in a study by Fortune Business Insights, the results of which were published on July 22, 2025.

Blood glucose measurement devices are used by patients with diabetes. Such devices help keep sugar readings within normal limits by preventing the development of health-threatening conditions, including hyperglycemia (too much glucose) or hypoglycemia (reduced glucose concentration). In type 1 diabetes, glucose is recommended to be tested up to 10 times a day. Modern monitoring systems simplify this process, allowing you to track indicators in a continuous mode. If necessary, insulin may be injected.

Global Sales of Glucose Monitoring Systems Totaled $17.2 Billion for the Year

One of the main drivers of the market, the authors of the study name the growing prevalence of diabetes mellitus. According to data published in 2024 in The Lancet magazine, the number of adults living with this ailment worldwide has exceeded 800 million, that is, it has jumped more than four times since 1990. The greatest increase is in low- and middle-income countries, where a sharp increase in the incidence of diabetes is accompanied by chronically low rates of access to treatment. This trend has led to significant global inequality: in 2022, almost 450 million adults over 30 years old, or about 59% of the total adult population with diabetes, remained without treatment, which is 3.5 times more than in 1990.

Diabetes causes blindness, kidney failure, heart attacks, strokes and often leads to the need for amputation of the lower extremities. According to estimates, in 2021, more than 2 million people died from diabetes and kidney diseases caused by it. In addition, about 11% of deaths from cardiovascular diseases were caused by a high blood sugar content. In such a situation, the need for glucose monitoring systems is growing.

Technological advances have a positive impact on the industry. Continuous sugar monitoring devices provide minimal invasiveness, speed and accuracy of results, as well as the ability to track indicators in real time. The use of such devices increases the quality of life of patients with diabetes and reduces the risks of complications. In addition, current continuous glucose monitoring systems integrate with wearable devices and insulin pumps, providing patients with comprehensive diabetes management solutions.

Analysts segment the market into continuous and self-controlled blood glucose systems. In 2024, the lion's share of revenue was provided by solutions of the first type. In general, monitoring devices in 2024 were most in demand among patients with type 2 diabetes due to its growing prevalence. Geographically, North America leads with 44% of revenue, or $7.57 billion. Significant industry players on a global scale are:

• Abbott;
• Braun SE;
• Dexcom;
• Ascensia Diabetes Care Holdings AG;
• Medtronic;
• Hoffmann-La Roche;
• Terumo;
• LifeScan IP Holdings;
• Senseonics.

The market is expected to reach $18.03 billion in 2025. Fortune Business Insights analysts believe that in the future, the CAGR will be 6.3%. Thus, by 2032, sales may increase to about $27.73 billion.^[1]

The volume of the global market for glucometers for the year reached $12.63 billion

At the end of 2024, sales of glucometers on the global market amounted to $12.63 billion. The industry is showing sustained positive momentum, according to a review by The Insight Partners, which Zdrav.Expert reviewed in early July 2025.

Glucometers are special devices that allow people with diabetes to control their blood glucose levels. Such portable devices help keep sugar rates within normal limits by preventing the development of health-threatening conditions such as hyperglycemia (too much glucose) or hypoglycemia (reduced glucose concentration). Regular monitoring of sugar levels makes it possible to optimize diet and physical activity, as well as determine drug treatment if necessary. Thus, glucometers contribute to improving the quality of life of patients and reducing the risks of complications.

One of the market drivers analysts call the increase in the prevalence of diabetes mellitus. According to the World Health Organization (WHO), from 1990 to 2022, the number of people with this disease increased from 200 million to 830 million people, that is, more than four times. The prevalence of diabetes in the adult population rose from 7% to 14%. The greatest increase is in low- and middle-income countries, where a sharp increase in incidence is accompanied by low rates of access to treatment. According to estimates, in 2021, more than 2 million people died from diabetes and kidney diseases caused by it. In addition, about 11% of cardiovascular deaths were caused by high blood sugar. Against this background, the demand for glucose meters is growing, which help to control glucose indicators. In 2023, WHO included personal glucose devices in the list of essential diagnostics: this is expected to help reduce the number of adverse diabetes outcomes.

We note the alarming increase in the incidence of diabetes, which is a consequence of the increase in obesity, fueled by the advertising of unhealthy foods, low levels of physical activity and the disadvantaged economic situation of certain groups of the population. To curb the global diabetes epidemic, countries are required to take urgent measures, says WHO Director-General Dr. Tedros Adhanom Ghebreyesus.

Technological advances also contribute to the increase in sales of glucometers. Modern devices offer a number of additional functions, such as sound reminders, the ability to store previous measurements, connection to a smartphone, etc. A wide range of over-the-counter devices allows you to meet various patient requirements. Advanced systems are available for continuous glucose monitoring.

In 2024, North America provided the largest share in the total sales of glucometers. Next comes Europe, and the Asia-Pacific region closes the top three, which is showing the highest growth rates. Globally, significant players are named:

• B. Braun SE;
• F. Hoffmann-La-Roche;
• LifeScan;
• Medtronic;
• Abbott Laboratories;
• Ypsomed Holding AG;
• Sensionics;
• Nipro;
• GE Healthcare;
• Terumo.

Analysts at The Insight Partners believe that in the future, the CAGR in the market under consideration will be about 12.6%. As a result, by 2031, sales of glucose meters worldwide could increase to $32.97 billion.^[2]

Pilot project launched in Russia to control glycemia levels in patients with diabetes mellitus

A pilot project has been launched in Russia to control the level of glycemia in patients with diabetes mellitus. The program covers 6 regions of the country and more than 2000 patients with type 1 and type 2 diabetes. Gagik Galstyan, President of the Russian Diabetes Association, spoke about the main tasks of the project on November 14, 2024. Read more here.

Roszdravnadzor has registered the Syai continuous glucose monitoring system Kh1

Roszdravnadzor has registered the Syai Kh1 continuous glucose monitoring system. AstraZeneca announced this on October 21, 2024. Read more here.

The first laboratory sample of a flexible glucose sensor that does not require skin puncture was created in Russia

Researchers from the Rzhanov Institute of Semiconductor Physics SB RAS (IFP SB RAS) create electronic flexible glucose sensors that do not require skin puncture. On July 10, 2024, the IFP SB RAS presented a laboratory sample operating at a low recording speed (signal accumulation time 10-30 minutes). As representatives of the institute told the medical portal Zdrav.Expert, the device detects the level of glucose in sweat and will be useful for patients with diabetes mellitus, as well as for those who need to control the level of glucose in the body - for example, athletes or people following a specialized diet. Read more here.

US authorities urged diabetics not to measure blood sugar with smartwatches and rings

In February 2024, the US Food and Drug Administration (FDA) urged users not to measure blood glucose with smartwatches and rings, since, according to the department, such devices use algorithmic calculations that are far from those shown by medical equipment.

The regulator claims that measurements using smartwatches and rings can lead to errors in the treatment of diabetes, including taking too much or too little medicine. These non-invasive measurements differ from continuous glucose monitoring (CGM) devices, which transmit data through smartwatch applications.

FDA urges users not to measure blood glucose with smartwatches and rings

According to manufacturers of such "smart" watches and rings, their gadgets can measure blood glucose levels using optical or electrical signals. However, the FDA warns that such devices can produce inaccurate or inconsistent results. This could result in diabetic patients taking the wrong amount of insulin or other medications, which could cause hypoglycemia or hyperglycemia, the office said in a statement.

Some unscrupulous manufacturers of smart rings and watches claim that their devices are capable of performing non-invasive blood glucose measurements. These devices are sold on Internet marketplaces, manufacturers' websites and through crowdfunding campaigns. The FDA encourages consumers to report similar offers through MedWatch's online voluntary reporting form.

By February 2024, Apple is developing an Apple Watch with non-invasive sugar measurement. In particular, the company is studying optical absorption spectroscopy using a laser to transmit light under the skin to determine the level of glucose in human blood.^[3]

The prosecutor's office in the Novosibirsk region began checking the procurement of Chinese systems that harm diabetic children

On January 29, 2024, the Prosecutor's Office of the Novosibirsk Region initiated a quality check of medical devices purchased by the Ministry of Health of the region for children suffering from type 1 diabetes. We are talking about Chinese blood glucose monitoring systems of the Dr Brinner brand, which, as stated, can harm patients. Read more here.

2023

Mishustin allocated 5.1 billion rubles for the purchase of continuous glucose monitoring devices for children

Prime Minister Mikhail Mishustin signed a decree that allocated more than 5.1 billion rubles for the purchase of portable continuous glucose monitoring systems. We are talking about the supply of this equipment in 2023-2024. for children with diabetes. The corresponding document was published in November 2023.

As explained in the government, the decision to allocate federal funding to the regions will provide glucose monitoring systems for all children in need of them with type I diabetes mellitus aged 2 to 17 years inclusive. Prescriptions for free receipt of such systems will be written by attending endocrinologists. All Russian regions will receive federal funds on co-financing terms. In 2023, their volume will be just over 1 billion rubles, in 2024 - 4.1 billion rubles. Previously, providing children with such portable systems was exclusively at the expense of regional budgets, which affected their availability.

The Cabinet emphasized that for children with type I diabetes mellitus, constant control of blood glucose is critically necessary to adjust the dose of insulin administered. Unlike classic glucose meters with test strips, continuous monitoring systems use subcutaneous sensors that work for a long time. These devices provide 24-hour glucose monitoring and help you notice a decrease or increase in glucose in time. The use of such devices will significantly improve the quality of life of families raising children with type I diabetes.

The President instructed the government to achieve the availability of portable systems for continuous glucose monitoring Russia Vladimir Putin following a meeting with members of the Cabinet of Ministers, which took place in September 2023.

Government of the Russian Federation Resolution of November 22, 2023 No. 1640

A device for measuring blood sugar levels, connected to the USB connector of a smartphone, has been released

On November 1, 2023, DarioHealth announced its new development, a blood sugar meter connected to the iPhone 15. The launch is timed to coincide with the month of diabetes in the United States. Read more here.

Medtronic releases hand-worn blood glucose sensor

On September 21, 2023, Medtronic, one of the largest manufacturers of medical devices, announced the release of a wearable device for continuous blood glucose monitoring. A disposable product designed for people with diabetes is called Simplera. Read more here.

Petersburg company presented a non-invasive glucometer

In mid-June 2023, Brain Beat introduced a non-invasive glucometer based on bloodless and painless measurement of radiation in the optical region of the glucose absorption spectrum. The measurement speed is 30 seconds. Read more here.

Presented a wearable device for glucose control without finger puncture

On June 7, 2023, Know Labs announced the development of the Bio-RFID Gen 1 device designed for non-invasive blood glucose monitoring in patients with diabetes mellitus. In the future, the solution is expected to help improve the quality of life of millions of people around the world. Read more here.

Huawei launches smartwatch with blood sugar control

On May 18, 2023, the Chinese company Huawei launched the Watch 4 and Watch 4 Pro smart wristwatches, the creation of which paid special attention to health functions. Read more here.

A clip has been developed in Russia to check blood glucose levels without a puncture

In early March 2023, it became known about the creation in Russia of a new wearable device for monitoring blood glucose levels without an AnnNIGM puncture. An optical sensor in a glucometer shines through tissues using infrared light and is able to "see" how much glucose is in the blood. Read more here.

2022

A device connected to a smartphone has been released to support the health of elderly diabetics

In early December 2022, California-based medical technology company Bigfoot Biomedical launched the Bigfoot Unity System device for diabetic patients on multiple daily injection therapy. The system uses continuous glucose monitoring data and physician recommendations to provide insulin dose recommendations, helping patients avoid uncertainty. Read more here.

An implantable sensor has been created that will replace the glucometer for diabetics

In mid-November 2022, a study conducted at the Ulsan National Institute of Science and Technology talks about a new way to measure blood sugar without taking blood.

This is a non-invasive method for measuring blood glucose using an electromagnetic (EM) wave glucose sensor injected under the skin. This discovery has attracted great attention because it eliminates the need for diabetic patients to constantly pierce their fingers with a glucometer. This study was led by Professor Franklin Bien and his research team in the Department of Electrical Engineering.

In this study, scientists proposed an electromagnetic-based sensor that can be implanted subcutaneously and is able to track minute changes in dielectric constant due to changes in blood sugar. The proposed sensor, which is about one-fifth the size of a cotton swab, can measure changes in glucose concentration in interstitial fluid (IL) - the fluid that fills the spaces between cells. The results of the study were published in the journal Scientific Reports for 2022.

Diabetes can be diagnosed if fasting blood glucose is 126 mg/dL or higher. The normal fasting glucose test result is less than 100 mg/dL. One of the main goals of diabetes management is to maintain blood glucose levels within a given target range. More than 400 million people worldwide live with diabetes and they still suffer from finger-pricking several times a day to check their blood glucose levels.

The research team also performed an intravenous glucose tolerance test (IVGTT) and an oral glucose tolerance test (OGTT) with sensor implantation to pigs and beagles in a controlled environment. According to the scientists, the results of the initial experiment inside a living organism showed a promising correlation between sugar levels and the frequency response of the sensor.^[4]

Free provision of glucose monitoring systems for children with diabetes in Moscow approved

In September 2022, Moscow Mayor Sergei Sobyanin signed a decree approving the free provision of glucose monitoring systems for children with diabetes in the capital. Read more here.

Popular diabetes control devices Insulet turned out to be defective

On October 17, 2022, Insulet said it had received reports that some Omnipod DASH users had problems with the batteries of their PDM devices, including a bloating battery, leaking liquid from the battery and, in rare cases, severe overheating. The company said it had not yet received reports of any injuries related to battery problems. Read more here.

Smart necklace with glucose by sweat function released

In early August 2022, Ohio State University researchers unveiled a device that can be worn around the neck to monitor a person's glucose levels by sweat secretions during exercise. Read more here.

Eversense Glucose Monitoring System Released, Running Continuously for 180 Days

On June 16, 2022, Senseonics launched Eversense E3 CGM glucose monitoring system, which operates continuously for 180 days. The device of the previous generation worked only 90 days. Read more here.

Abbott Wearable Biodevice for Continuous Blood Glucose and Ketone Monitoring

On June 3, 2022, Abbott announced a bio-device that is capable of continuously monitoring glucose and ketone body levels in a single sensor. The device is designed to improve the lives of people with life-threatening or irreversibly weakening diseases for the human body. Read more here.

D-Pocket Blood Glucose System

February 18, 2022 DiaMonTech introduced a patented technology platform operating in the middle infrared band and allowing non-invasive measurement of glucose blood levels in using painless laser detection. According to company representatives, the ease of use of the platform is comparable to the fingerprint sensor on a smartphone, and experts also strive to ensure that the platform allows you to control blood glucose levels without finger pricks and test strips. More. here

Roche Cobas Pulse glucometer with connection to Android smartphones

January 12, 2022 Roche announced the entry into the market of the glucometer. In Cobas Pulse particular, the novelty for control diabetes mellitus goes on sale in countries. Europe More. here

2021

Marriage detected on mySugr Bolus Calculator diabetes app Roche

In early April 2021, Roche acknowledged the marriage on the mySugr Bolus Calculator diabetic app, as this calculator recommended patients be given the wrong dose of insulin. The company said that the problem concerns applications versions 3.71.0, 3.72.0, 3.73.0 and 3.74.0, that is, all versions released since August 23, 2020. Read more here.

Roche Accu-Chek Instant Announcement - Glucose Monitoring Systems with Smartphone Connection

In mid-March 2021, the company Roche released a new system for monitoring blood glucose Accu-Chek Instant with a connection to. to the smartphone Roche thereby provides tools for an integrated personalized approach to managing diabetes mellitus, which aims to personalize treatment with improved clinical outcomes. More. here

Announcement of Quantum Operation - a bracelet for measuring blood glucose

In mid-January 2021, the Japanese company Quantum Operation presented at the CES consumer electronics show, according to the company, the world's first bracelet that continuously measures glucose levels. Monitoring is activated with one touch, and after 20 seconds, the owner receives data on blood sugar levels on the device screen. Read more here.

2019

Roche releases Accu-Chek SugarView app for detecting blood sugar using smartphone camera

In December 2019, Roche released a mobile application for determining blood glucose using a special test strip. The user just needs to point the smartphone camera at this strip and take two photos. Read more here.

Glasses are released that measure glucose from a diabetic's tear

In early December 2019, glasses were released that can track blood sugar levels through tear fluid. Read more here.